J3263 – Injection, toripalimab-tpzi, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ3263
- Long description
- Injection, toripalimab-tpzi, 1 mg
- Short description
- Inj, toripalimab-tpzi, 1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- July 1, 2024
- Last change
- July 1, 2024 – No change
Frequently asked questions
What is HCPCS code J3263?
J3263 is a HCPCS Level II code for injection, toripalimab-tpzi, 1 mg.
Does Medicare cover J3263?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J3243 – Injection, tigecycline, 1 mg
- J3244 – Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
- J3245 – Injection, tildrakizumab, 1 mg
- J3246 – Injection, tirofiban hcl, 0.25 mg
- J3247 – Injection, secukinumab, intravenous, 1 mg
- J3250 – Injection, trimethobenzamide hcl, up to 200 mg
- J3260 – Injection, tobramycin sulfate, up to 80 mg
- J3262 – Injection, tocilizumab, 1 mg
- J3265 – Injection, torsemide, 10 mg/ml
- J3268 – Injection, delafloxacin, 1 mg
- J3280 – Injection, thiethylperazine maleate, up to 10 mg
- J3285 – Injection, treprostinil, 1 mg
- J3290 – Injection, tranexamic acid, 5 mg
- J3291 – Injection, tranexamic acid in sodium chloride, 5 mg
- J3299 – Injection, triamcinolone acetonide (xipere), 1 mg
- J3300 – Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.